Peter Mac CoE in Cellular Immunotherapy

The Peter Mac's CoE in Cellular Immunotherapy mission is to discover, develop and deliver breakthroughs in CAR-T & other cell immunotherapies to treat cancer

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Great to see our consensus guidelines on CD20x3 #bispecific safety management in a nice PDF @bloodjournal https://t.co/g6qFvtfWPy. Hopefully a useful resource for the roll out of these potent drugs #lymsm #glofitamab #Epcoritamab #mosunetuzumab

[Peter Mac Cancer Centre @PeterMacCC]

Today we welcomed Kassem Younes, General Manager of Middle East, Türkiye and Africa for Global Victoria who facilitate trade and investment between Victoria and the Middle East and Africa. @JohnstoneRicky led a tour of his lab plus two of our key areas @PeterMacCoE and @pros_tic

[Snowdome Foundation @SnowdomeAU]

Congratulations to A/Prof @JaneOliaro of @PeterMacRes and @PeterMacCoE and Prof Richard Lock of @KidsCancerInst, the latest recipients of the @llsusa, Snowdome and @LeukaemiaAus. Australian translational research programme into blood cancer.
🔗https://t.co/6urQ9olswE

[Leukaemia Foundation @LeukaemiaAus]

Each year we join forces with @LLSusa & @SnowdomeAU to identify & fund new translational research projects.
Congratulations Assoc. Professor Jane Oliaro @PeterMacRes and Professor Richard Lock @KidsCancerInst!
Learn more: https://t.co/Th2jxNzo12

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Congratulations to CoECIT chief scientist A/Prof Jane Oliaro for receiving funding from the Leukaemia Foundation, Snowdome Foundation and LLS for her project “Making CAR T-cell therapy more effective for aggressive lymphoma and multiple myeloma” https://t.co/3UBZUJ87k5.

[Peter Mac Cancer Centre @PeterMacCC]

Today is #InternationalClinicalTrialsDay. It takes a huge team of people to make clinical trials happen, thank you to everyone involved in the journey. Read one of our amazing clinical trial stories here: https://t.co/1wHPhOm5gd
#CTD2022 #clincialtrialsday @PeterMacRes

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

@PeterMacCoE Chief Scientist A/Prof @JaneOliaro highlighting the goals of the COE at the PeterMac Research Retreat @PeterMacRes

[Peter Mac Cancer Centre @PeterMacCC]

Building international partnerships with leaders in Cellular Immunotherapy across time zones this morning with @UofPenn and @PeterMacCC experts sharing up-to-the-minute research to improve treatments for cancer patients across the world. @PeterMacCoE

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Congrats to all involved in this study #kymriah #CARTtherapy #cellularimmunotherapy

[Michael Dickinson @mike_dickinson1]

Really pleased to have been part of the team @PeterMacCC @PeterMacCoE who contributed very substantially to this global trial of #CART cells #kymriah #tisagenlecleucel in follicular #Lymphoma @lymphomaOz https://t.co/TrnWZJlRi0

[Nucleus Plus: CAR T @Emerging_CAR_T]

#CARTcell on our journal: "While acknowledging that there are no approved CAR T-cell therapies for CLL yet, this comprehensive review explores novel targets for CAR T-cell therapy in CLL and highlights the promising results of CAR T-cell trials to date."

https://t.co/p1dDw5CYAF

[Michael Dickinson @mike_dickinson1]

#ash21 late breaking abstracts are out https://t.co/krFEb6KbJY Definitely some food for thought with #polarix and #belinda abstracts now available #lymsm

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Great article @LeukaemiaAus and Deputy Clinical Director of the CoE CIT, @mike_dickinson1 Thanks for sharing @CellTherapies_ #CART #celltherapy #cellularimmunotherapy

[Cell Therapies Pty Ltd @CellTherapies_]

Deputy Clinical Director of the CAR T-cell service at @PeterMacCC, Associate Professor Michael Dickinson provides a fantastic overview of #cartcelltherapy and the ongoing development and manufacturing of products in Australia. https://t.co/CwvKaaVpOI

[Peter Mac Cancer Centre @PeterMacCC]

Peter Mac is pleased to announce that Professors
@LoiSher, @McArthurGrant, @bensolomon1 and Phillip Darcy have all been named in the annual Highly Cited Researchers List for 2021 for their exceptional citation impact in their field #highlycited2021 https://t.co/mnBdqIwGxA

[Cell Therapies Pty Ltd @CellTherapies_]

The RM Catalyst recently published two reports revealing Australia's potential to become a global leader in the #regenerativemedicine sector from both a manufacturing and clinical trial perspective.

Click here to read: https://t.co/nKpAIsKl7O

#cellandgenetherapies @AusBiotech

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

A big congratulations to these PeterMac researchers awarded NHMRC grants @PeterMacRes

[Peter Mac Cancer Centre @PeterMacCC]

Eight Peter Mac scientists who are pioneering new treatments and advancing understanding of #cancer have secured more than $9.6 million in funding from @nhmrc. Big congratulations all! Click the link to read more about our scientists and their #research https://t.co/2qrluwwkft

[Peter Mac Cancer Centre @PeterMacCC]

Eight Peter Mac scientists who are pioneering new treatments and advancing understanding of #cancer have secured more than $9.6 million in funding from @nhmrc. Big congratulations all! Click the link to read more about our scientists and their #research https://t.co/2qrluwwkft

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Peter Mac's CoE CIT is excited to announce our new partnership with @CellVecHQ
"This partnership with CellVec will underpin and enable a pipeline of high-potential research focused on developing the next generation of immunotherapies" - CoECIT director, Prof Simon Harrison

[CellVec @CellVecHQ]

#CellVec enters strategic partnership with @PeterMacCC to supply #viralvectors for cell-based #immunotherapies for #cancertreatment.

Check it out here: https://t.co/CHetNKhKr8

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

Peter Mac’s Centre of Excellence in Cellular Immunotherapy has established a new dedicated laboratory to rapidly progress its cell-based immunotherapy breakthroughs into clinical trials.
The CoE CIT Translation Laboratory (CoE-Lab) is lead by A/Prof Jane Oliaro, Chief Scientist

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

September is #BloodCancerAwarenessMonth. The @PeterMacCoE is committed to ongoing research and translation of life-saving CAR-T and other cellular immunotherapies for #BloodCancer @LeukaemiaAus

[Peter Mac CoE in Cellular Immunotherapy @PeterMacCoE]

A huge congratulations to COE clinician-scientist Dr. Katherine Cummins on this accomplishment. #WomeninScience

[Peter Mac Cancer Centre @PeterMacCC]

A big congrats to Dr @KathDCummins who has been awarded the the Gunn Family Women in Haematology Fellowship supported by @MaddiesVision and @SnowdomeAU. Read more about Dr Cummins' research into #AcuteMyeloidLeukaemia treatment resistance. #WomeninScience https://t.co/EOImqVn5AE